VacZine Analytics  
MarketVIEW: Cholera vaccines

Published: September 2016

Cholera is a rapidly dehydrating diarrheal disease caused by the ingestion of Vibrio cholera. The infection is primarily linked to insufficient access to safe water and proper sanitation. Cholera causes a major burden of disease in Asia, sub-Saharan Africa and Hispaniola. Globally an estimated 2.86 million cholera cases occur annually in endemic countries causing 95,000 deaths. 1.3 billion people are believed to be at risk. Cholera is relatively rare in travellers to cholera-endemic countries.

This MarketVIEW product is composed of two comprehensive MS Excel-based models + summary presentation that forecasts the potential commercial value of cholera travel vaccines across major Western markets of traveler origin to 2030. Two scenarios are included based on the potential regulatory approval of PaxVax’s Vaxchora outside the US market. Full traveler modelling assumptions are clearly indicated with a detailed build-up worksheet per country of origin. An up to date review of cholera epidemiology is also included along with some discussion of endemic use and other relevant topics.

THIS PRODUCT IS A SUMMARY PRESENTATION + 2 MODELs

To order please contact your region account manager, buy "on-line" or order direct at: orders@vaczine-analytics.com

CAT No: CONTENTS: PURCHASE:
VAMV069 Click here>>
Choose option:
*Prices quotes are for 1 region license only. Regions are North America, or EU or ROW. For UK orders VAT will be added at 20%. Please review the TERMS and CONDITIONS of purchase.

Return to main list>> Questions about this report?






© 2016 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. hosted by chillydomains